Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech World Canada.
Press releases published on April 1, 2025

Dark Table CCG to Launch On-Chain Game with Support from Somnia & Uprising
New York, NY, April 01, 2025 (GLOBE NEWSWIRE) -- Dark Table CCG, the world’s first Cross-Collectible (C2) Card Game, has been accepted into the Dream Catalyst accelerator, an initiative by Somnia and Uprising Labs designed to support innovative, on-chain …

POET Receives Lightwave Award for Outstanding AI Hardware at OFC Conference
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- POET Technologies Inc. ("POET" or the "Company") (TSX Venture: PTK; NASDAQ: POET), a leader in the design and implementation of highly integrated optical engines and light sources for artificial intelligence …

AI & Technology Virtual Investor Conference Agenda Announced for April 3rd
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the AI …

Zefiro Methane Corp. Subsidiary Completes Package of State-Funded Oil and Gas Well Remediation Projects in Pennsylvania
FORT LAUDERDALE, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) today announced that its subsidiary Plants …

ENTOUCH Unveils Revolutionary ENTelligent Insights to Transform Energy Management
Continued Machine Learning Expansion Leads the Energy Management Offering RICHARDSON, TX, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- ENTOUCH, a leader in energy management and smart building technology for multisite operators, proudly announces …

Cannabix Technologies to Attend U.S. National Drug and Alcohol Conference to Market Marijuana Breath Test
VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that it will …

Aptose Common Shares to Delist from Nasdaq as of April 2, 2025
SAN DIEGO and TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:APS), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment
The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind’s innovative, psychedelic-derived, MEAI-based compound in individuals with alcohol addiction Vancouver, Canada, April 01, 2025 (GLOBE NEWSWIRE) -- Clearmind …

Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes
DSMB supports advancement for Sernova’s clinical trial Study is on track to meet key clinical trial endpoints LONDON, Ontario and BOSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading …

MariMed Launches Nature’s Heritage™ Flower in Illinois
NORWOOD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, has officially introduced its Nature’s Heritage™-branded cannabis flower, …

Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, …

LeddarTech apporte d’autres modifications à sa facilité de crédit et à son offre de financement relais et annonce la réception d’un avis d’insuffisance du NASDAQ
QUÉBEC, Canada, 01 avr. 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (« LeddarTech ») (NASDAQ : LDTC), une société de logiciels automobiles qui fournit des technologies logicielles de fusion bas niveau de capteurs et de perception alimentées par l’IA …

LeddarTech Enters Into Further Amendments to Credit Facility and Bridge Financing Offer and Announces Receipt of Nasdaq Deficiency Notice
QUEBEC CITY, Canada, April 01, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-powered low-level sensor fusion and perception software technology, …

Digi Power Reports 115% Quarterly Revenue Growth in Q1 2025, Maintains Debt-Free Operations and Strengthens Cash Position
MIAMI, April 01, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), an innovative energy infrastructure company that develops cutting-edge data centers, is pleased to provide unaudited comparative …

NEXTGEN DIGITAL ANNOUNCES NON-BROKERED PRIVATE PLACEMENT OF SPECIAL WARRANTS AND/OR COMMON SHARES
Fredericton, New Brunswick, April 01, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) is pleased to announce that it is undertaking a non-brokered private placement of up to 10,000,000 …

Planet 13 Announces Grant of RSUs
LAS VEGAS, April 01, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, announced that it granted Restricted Stock Units (“RSUs”) to …

Treatment.com AI and Aiyibotong collaborate to explore commercial opportunities for Clinical Decision Support in China and Far East
Market for Clinical Decision Support (CDSS) in China is ~US$600 million by 2030 Aiyibotong has installed systems in >200 healthcare institutions in China Aiyibotong and Treatment.com AI both using proprietary artificial intelligence (AI) and Machine …

Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, …

POET Technologies Reports Fourth Quarter 2024 Financial Results
TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center …

Renowned Biomedical Scientist Franco Cavaleri Challenges Conventional Alzheimer's Theories in Groundbreaking Study
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- Franco Cavaleri, B.Sc., Ph.D.c, a distinguished biomedical research scientist and CEO of Biologic Pharmamedical Research and Manufacturing, has published a pioneering study that reexamines the …